Abnormal Uterine Bleeding

  • Devendra Naik


Abnormal uterine bleeding is a disorder of menstruation and represents a change in the menstrual pattern.


Corpus Luteum Tranexamic Acid Uterine Fibroid Mefenamic Acid Menstrual Bleeding 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Hatasaka H. The evaluation of abnormal uterine bleeding. Clin Obstet Gynecol. 2005;48:258–73.CrossRefPubMedGoogle Scholar
  2. 2.
    Spencer CP, Whitehead MI. Endometrial assessment re-visited. Br J Obstet Gynaecol. 1999;106:623–32.CrossRefPubMedGoogle Scholar
  3. 3.
    Cohen BJB, Gibor Y. Anaemia and menstrual blood loss. Obstet Gynaecol Sur. 1980;35:597–618.Google Scholar
  4. 4.
    Shaw RW, Luesley D, Monga AK. Gynaecology: Expert Consult: Online and Print, 3rd ed. Churchill Livingstone (Elsevier): 2011, p. 464. ISBN 13 - 9780702031205.Google Scholar
  5. 5.
    Rybo G. Plasminogen activator in the endometrium.II.Clinical aspects. Acta Obstet Gynecol Scand. 1966;45:97–118.CrossRefGoogle Scholar
  6. 6.
    ACOG Practice Bulletin. Management of anovulatory bleeding. Intl J Gynaecol Obstet. 2001;73:263–71.Google Scholar
  7. 7.
    Slap GB. Menstrual disorders in adolescence. Best Pract Res Clin Obstet Gynaecol. 2003;17:75–92.CrossRefPubMedGoogle Scholar
  8. 8.
    Awonuga AO, Imudia AN, Shavell VI, Berman J, Diamond MP, Puscheck EE. Failed female sterilization: a review of pathogenesis and subsequent contraceptive options. J Reprod Med. 2009;54:541–7.PubMedGoogle Scholar
  9. 9.
    Tibbles CD. Rosen’s emergency medicine – concepts and clinical practice, 7th ed., Vol. 2, Philadelphia: Mosby Elsevier; p. 1331.Google Scholar
  10. 10.
    Espindola D, Kennedy KA, Fischer EG. Management of abnormal uterine bleeding and the pathology of endometrial hyperplasia. Obstet Gynecol Clin N Am. 2007;34:717–37.CrossRefGoogle Scholar
  11. 11.
    Latheby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev. 2007;(4):CD000400.Google Scholar
  12. 12.
    Frase IS, Porte RJ, Kouides P, Lukes AS. A benefit-risk review of systemic haemostatic agents: part 2: in excessive or heavy menstrual bleeding. Drug Saf. 2008;31:275–82.CrossRefGoogle Scholar
  13. 13.
    Lobo RA. Abnormal uterine bleeding. In: Katz VL, Lentz GM, Lobo RA, Greshenson DM, editors. Comprehensive gynecology. Philadelphia: Mosby; 2007. p. 915–31.CrossRefGoogle Scholar
  14. 14.
    DeVore GR, Owens O, Kase N. Use of intravenous Premarin in the treatment of dysfunctional uterine bleeding- a double blind randomized control study. Obstet Gynecol. 1982;59:285–91.PubMedGoogle Scholar
  15. 15.
    Beaumont HH, Augood C, Duckitt K, Lethaby A. Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev. 2007;(3):CD001017.Google Scholar
  16. 16.
    Wallach EE, Vlahos NF. Uterine myomas: an overview of development. Obstet Gynecol. 2004;104:393–406.CrossRefPubMedGoogle Scholar
  17. 17.
    Baakdah H, Tulandi T. Uterine fibroid embolization. Clin Obstet Gynecol. 2005;48:361–8.CrossRefPubMedGoogle Scholar
  18. 18.
    McGurgan P, O’Donovan P. Second-generation endometrial ablation: an overview. Best Pract Res Clin Obstet Gynecol. 2007;21:931–45.CrossRefGoogle Scholar

Copyright information

© Springer India 2016

Authors and Affiliations

  1. 1.Emergency MedicineFortis Hospitals LimitedBengaluruIndia

Personalised recommendations